Cargando…

Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department

We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7% respectively. This facilitates faster clinical decision-making, along with the rapid implementation of infection control measures, and improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bousquet, Aurore, Larréché, Sébastien, Bigaillon, Christine, Woloch, Alexandre, Thomas, Léa, Conan, Pierre Louis, Mérens, Audrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188679/ https://www.ncbi.nlm.nih.gov/pubmed/35843113 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115742

Ejemplares similares

Role of Hologic® Panther Aptima™ SARS-CoV-2 assay in the detection of SARS-CoV-2: screening or diagnostic technique?
por: García-Salguero, Cristina, et al.
Publicado: (2023)

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens
por: Trémeaux, Pauline, et al.
Publicado: (2020)

Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
por: de Salazar, Adolfo, et al.
Publicado: (2019)

Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay
por: Manak, Mark M., et al.
Publicado: (2017)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens
por: Venter, Johanna M. E., et al.
Publicado: (2019)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Development of real-time RT-PCR assays to detect measles virus on the Hologic Panther Fusion® System
por: Grant, Jenny, et al.
Publicado: (2023)

Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads
por: Sepulveda, Jorge L., et al.
Publicado: (2021)

The Hologic Aptima SARS‐CoV‐2 assay enables high ratio pooling saving reagents and improving turnaround time
por: Newsom, Kimberly, et al.
Publicado: (2021)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

Similar Sensitivity of SARS-CoV-2 Detection in Oropharyngeal/Nasopharyngeal and Saliva Samples on the Hologic Panther Platform
por: Vahidnia, Ali, et al.
Publicado: (2023)

Validation of the Hologic Aptima Unisex and Multitest Specimen Collection Kits Used for Endocervical and Male Urethral Swab Specimens (Aptima Swabs) for Collection of Samples from SARS-CoV-2-Infected Patients
por: Avaniss-Aghajani, E., et al.
Publicado: (2020)

A Study of Analytical and Clinical Sensitivity of Aptima SARS-CoV-2 Assay (Hologic) and Proposals of Complementary Tests for SARS-CoV-2 Detection in Low Viral Load Specimens
por: La, My-Van, et al.
Publicado: (2021)

Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples
por: Yan, Ying, et al.
Publicado: (2022)

Evaluation of Aptima Zika Virus Assay
por: Ren, Ping, et al.
Publicado: (2017)

Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs
por: Serei, Virian D., et al.
Publicado: (2021)

Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)

Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya
por: Mwau, Matilu, et al.
Publicado: (2022)

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Evaluation of the COVID19 ID NOW EUA assay
por: Mitchell, Stephanie L., et al.
Publicado: (2020)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2
por: Gorzalski, Andrew J., et al.
Publicado: (2020)

Verification of dried blood spot as a sample type for HIV viral load and early infant diagnosis on Hologic Panther in Zambia
por: Simushi, Precious, et al.
Publicado: (2023)

Evaluation of the Aptima(®) HIV‐1 Quant Dx assay for HIV‐1 RNA viral load detection and quantitation in plasma of HIV‐1‐infected individuals: A comparison with Abbott RealTime HIV‐1 assay
por: Amendola, Alessandra, et al.
Publicado: (2016)

Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0
por: Worlock, A., et al.
Publicado: (2017)

Comparison of the Quidel Sofia SARS FIA Test to the Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of COVID-19 in Symptomatic Outpatients
por: Beck, Eric T., et al.
Publicado: (2021)

One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™
por: Burnes, Laura E, et al.
Publicado: (2021)

Comparison of Abbott ID NOW, a novel isothermal amplification based COVID-19 diagnostic method with RTPCR
por: Srivastava, Smriti, et al.
Publicado: (2022)

678. Rapid Molecular SARS-CoV-2 Detection by Abbott ID NOW Is Reliable in Pediatric Patients
por: Murphy, Catherine, et al.
Publicado: (2021)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study
por: Schwebke, Jane R., et al.
Publicado: (2020)

Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2
por: Pattnaik, Dipti, et al.
Publicado: (2022)

Multi-center clinical evaluation of the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay in nasopharyngeal swab specimens from symptomatic individuals
por: Sasidharan, Anjana, et al.
Publicado: (2023)

Combined SARS-CoV-2 nucleic acid amplification testing and respiratory virus panel RT-PCR on the Hologic Panther Fusion system
por: Stevens, Bryan A., et al.
Publicado: (2021)

Comparison of the Panther Fusion and BD MAX Group B Streptococcus (GBS) Assays for Detection of GBS in Prenatal Screening Specimens
por: Berry, Gregory J., et al.
Publicado: (2019)

The ID NOW COVID-19, a high-speed high-performance assay
por: Farfour, Eric, et al.
Publicado: (2021)

Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy
por: Bakkour, Sonia, et al.
Publicado: (2020)

Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario
por: Deslandes, Vincent, et al.
Publicado: (2022)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fg19eetu08aqi9r5b6chavdq5i